Laboratorios Richmond SACIF Total Assets

Latest as of September 2025: AR$354.98 Billion ARS ≈ $256.86 Million USD

Laboratorios Richmond SACIF total assets. Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) holds total assets worth AR$354.98 Billion ARS (≈ $256.86 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Laboratorios Richmond SACIF (RICH) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Laboratorios Richmond SACIF (2006–2024)

Total assets of Laboratorios Richmond SACIF from 2006 to 2024. This chart illustrates how Laboratorios Richmond SACIF's total assets have evolved over time, based on quarterly financial data. See RICH stock price for real-time trading data and today's change.

Laboratorios Richmond SACIF - Asset Composition Analysis

Laboratorios Richmond SACIF Total Assets Breakdown (December 2024)

Laboratorios Richmond SACIF total assets breakdown as of December 2024. Laboratorios Richmond SACIF's total assets of AR$354.98 Billion consist of 26.4% current assets and 73.6% non-current assets.

Asset Category	Amount (ARS)	% of Total Assets
Cash & Equivalents	AR$0.00	2.7%
Accounts Receivable	AR$28.17 Billion	10.8%
Inventory	AR$25.39 Billion	9.8%
Property, Plant & Equipment	AR$0.00	0.0%
Intangible Assets	AR$26.08 Billion	10.0%
Goodwill	AR$4.16 Billion	1.6%

Asset Composition Trend (2006–2024)

This chart illustrates how Laboratorios Richmond SACIF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore RICH current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Laboratorios Richmond SACIF's current assets represent 26.4% of total assets in 2024, an increase from 0.0% in 2006.
Cash Position: Cash and equivalents constituted 2.7% of total assets in 2024, down from 6.2% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 10.8% of total assets.

Laboratorios Richmond SACIF Competitors by Total Assets

Key competitors of Laboratorios Richmond SACIF based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥9.94 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥13.81 Billion
Shenzhen Chipscreen Biosciences Co SHG:688321	China	CN¥3.63 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
HPGC Renmintongtai Pharmaceutical Corp SHG:600829	China	CN¥7.35 Billion

Laboratorios Richmond SACIF - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.05	1.23	1.51
Quick Ratio	0.60	0.74	1.06
Cash Ratio	0.00	0.00	0.00
Working Capital	AR$4.32 Billion	AR$10.88 Billion	AR$1.82 Billion

Laboratorios Richmond SACIF - Advanced Valuation Insights

This section examines the relationship between Laboratorios Richmond SACIF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.25
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	-22.9%
Total Assets	AR$260.15 Billion
Market Capitalization	$66.97 Million USD

Valuation Analysis

Below Book Valuation: The market values Laboratorios Richmond SACIF's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Laboratorios Richmond SACIF's assets decreased by 22.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Laboratorios Richmond SACIF (2006–2024)

The table below shows the annual total assets of Laboratorios Richmond SACIF from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	AR$260.15 Billion ≈ $188.25 Million	-22.88%
2023-12-31	AR$337.32 Billion ≈ $244.09 Million	+728.40%
2022-12-31	AR$40.72 Billion ≈ $29.47 Million	+58.49%
2021-12-31	AR$25.69 Billion ≈ $18.59 Million	+215.90%
2020-12-31	AR$8.13 Billion ≈ $5.89 Million	+58.40%
2019-12-31	AR$5.13 Billion ≈ $3.72 Million	+89.81%
2018-12-31	AR$2.71 Billion ≈ $1.96 Million	+74.23%
2017-12-31	AR$1.55 Billion ≈ $1.12 Million	+80.30%
2016-12-31	AR$861.13 Million ≈ $623.12K	+61.61%
2015-12-31	AR$532.83 Million ≈ $385.56K	+38.16%
2014-12-31	AR$385.66 Million ≈ $279.06K	+34.20%
2013-12-31	AR$287.37 Million ≈ $207.94K	+6.06%
2012-12-31	AR$270.95 Million ≈ $196.06K	+70.39%
2011-12-31	AR$159.03 Million ≈ $115.07K	+17.12%
2010-12-31	AR$135.78 Million ≈ $98.25K	+6.21%
2009-12-31	AR$127.84 Million ≈ $92.51K	+27.03%
2008-12-31	AR$100.63 Million ≈ $72.82K	+29.71%
2007-12-31	AR$77.58 Million ≈ $56.14K	+37.67%
2006-12-31	AR$56.36 Million ≈ $40.78K	--

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic

Market Cap

$66.97 Million

AR$92.55 Billion ARS

Market Cap Rank

#20523 Global

#56 in Argentina

Share Price

AR$1390.00

Change (1 day)

+6.92%

52-Week Range

AR$1290.00 - AR$2165.00

All Time High

AR$2165.00